2017
DOI: 10.3892/mmr.2017.7250
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitory effect of curcumin in human endometriosis endometrial cells via downregulation of vascular endothelial growth factor

Abstract: Endometriosis, which affects up to 10% of women of reproductive age, is defined as endometrial-like gland and stroma tissue growths outside the uterine cavity. Despite increasing research efforts, there are no current effective treatment methods for this disease, therefore investigations for therapeutic strategies are of primary concern. In preliminary work, the authors demonstrated that curcumin inhibits endometriosis in vivo. The present in vitro study aimed to investigate the association between endometriot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(26 citation statements)
references
References 33 publications
1
24
0
1
Order By: Relevance
“…Vimentin spots were counted from more than 10 microscopic views. Microscopic images were processed as described . All experiments were in triplicate.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Vimentin spots were counted from more than 10 microscopic views. Microscopic images were processed as described . All experiments were in triplicate.…”
Section: Methodsmentioning
confidence: 99%
“…34 All experiments were in triplicate. Z-25307; Thermo Fisher Scientific) and stained with DAPI (1:1000; catalog no.…”
Section: Immunofluorescent Assaymentioning
confidence: 99%
See 1 more Smart Citation
“…Curcumin is a polyphenolic compound found in turmeric, which is derived from the rhizomes of the plant Curcuma longa Linn [ 81 ]. The anti-inflammatory and anti-proliferative effects of curcumin on endometriosis were reported previously in in vitro and animal studies [ 82 , 83 , 84 , 85 ]. The Vienna-based ENDOFLEX study is currently recruiting patients with endometriosis for an interventional clinical trial randomized for placebo versus the dietary supplement flexofytol, with planned administration of 42 mg of curcumin twice a day for a duration of 4 months.…”
Section: Diet and Nutrition In Endometriosismentioning
confidence: 65%
“…Following treatment with curcumin, an increase the percentage of cells in G1 and decrease in the percentage of S phase cells were observed among human endometriotic stromal cells, along with the reduced expression of VEGF. Curcumin has been shown to reduce cell proliferation, human ectopic and eutopic stromal cell growth, and inhibit VEGF secretion in humans [ 104 ]. Furthermore, curcumin inhibited cell proliferation and caused cell apoptosis, and reduced inflammation through suppression of inflammatory cytokines expression.…”
Section: Resultsmentioning
confidence: 99%